Data Snapshot: Oct 04, 2026
$100K+

Sep-2026

Sales

Neutral

Trend

6-Month

21

Product Count

SKUs

$72.17

Avg Price

-5.5%

YoY Sales Change

-15.9%

YoY Price Change

Head & Heal

Where to Buy

Head & Heal is stocked at 207 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Rochester, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/12142.json?v=20261004
Head & Heal Sales

Market Insights Snapshot

Head & Heal Historical Sales by Category

In September 2026, Head & Heal concentrated 75.94% of sales in Tincture & Sublingual, where category sales fell 28.07% year over year and 5.60% month over month, while the brand’s overall sales declined 5.49% YoY and average price dropped 15.90% YoY to $72.17. Concentrates expanded to 19.93% share with a 1.63% MoM lift, contrasting with Topical at 3.90% share that swung 1,514.25% YoY yet contracted 22.36% MoM, and Edible remained marginal at 0.24% share with an 11.13% MoM decline. The pattern indicates over-reliance on Tincture & Sublingual is amplifying volatility despite a relatively modest brand-level YoY decline, and the small but growing Concentrates mix offers a partial buffer if momentum persists.

Head & Heal holds rank 2 in Tincture & Sublingual in New York, yet the 28.07% YoY and 5.60% MoM contractions in that category, alongside a 15.90% YoY price reduction, point to a defensive posture anchored in price and incumbent position rather than mix diversity. The 1.63% MoM gain in Concentrates at 19.93% share versus the 22.36% MoM pullback in Topical at 3.90% share implies near-term upside is more achievable by deepening Concentrates penetration than by leaning on the volatile Topical surge, and maintaining rank in New York likely depends on stabilizing Tincture & Sublingual while using Concentrates to dilute category risk.

Sep-2026 Rank
Concentrates
Tincture & Sublingual
Topical
18
2
5
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
75.9%
$76.92
-28.1%
-5.6%
Concentrates
19.9%
$65.30
—
+1.6%
Topical
3.9%
$45.16
+1514.2%
-22.4%
Edible
0.2%
$34.22
—
-11.1%
Head & Heal

Competitive Landscape

Head & Heal sits at rank #2 in New York Tincture & Sublingual for September 2026, unchanged from rank #2 year over year, with its three-month position also steady at #2 and a historical peak at #1 in December 2024; meanwhile, Ayrloom held at #1 year over year with an 8.3% YoY sales increase, while Veterans Choice Creations (VCC) improved from #4 to #3 on a 10.5% YoY gain and Mfny (Marijuana Farms New York) slid from #3 to #4 amid a 26.5% YoY sales decline; this combination of Head & Heal’s flat rank alongside upward pressure from VCC and a stable leader at #1 implies a stalled return to #1 unless Head & Heal accelerates share capture against the rising #3.

Head & Heal market ranking for NY Tincture & Sublingual

Head & Heal

Notable Products

CBD Unscented Lotion (1000mg CBD) posted the steepest decline in September 2026 at -58.23% MoM and slid to rank 9, while CBD/THC 1:1 Lavender Scented Lotion (1000mg CBD, 1000mg THC, 50ml) dropped -29.80% MoM at rank 8, indicating a contraction in Topical demand that rebalances mix away from low-volume SKUs. At the top of the table, Max Strength THC Tincture (1000mg THC, 30ml, 1oz) fell -15.69% MoM to rank 2 even as CBD/THC/CBN 2:1:2 Sleep Tincture (600mg CBD, 300mg THC, 600mg CBN, 30ml) inched up +2.58% MoM to rank 1, narrowing the gap between THC-only and multi-cannabinoid sleep solutions; this tilt implies portfolio share concentrating in Tincture & Sublingual as three of the top five SKUs sit in that category. With CBD/THC 2:1 Relief Tincture up +5.66% MoM at rank 4 and CBG/THC 4:1 Focus Tincture up +3.90% MoM at rank 5, incremental gains across blended cannabinoid tinctures offset the topical declines, suggesting Head & Heal’s near-term commercial direction favors function-forward tinctures over peripheral topicals despite one topical still holding rank 6 with $3,013 in September 2026 sales.

Product
Category
May-2026
Jun-2026
Jul-2026
Aug-2026
Sep-2026
MoM %
CBD/THC/CBN 2:1:2 Sleep Tincture (600mg CBD, 300mg THC, 600mg CBN, 30ml)
Tincture & Sublingual
2
2
2
2
1
+2.6%
Max Strength THC Tincture (1000mg THC, 30ml, 1oz)
Tincture & Sublingual
1
1
1
1
2
-15.7%
Hybrid RSO Dablicator (1g)
Concentrates
3
3
3
3
3
+1.6%
CBD/THC 2:1 Relief Tincture (600mg CBD, 300mg THC, 30ml)
Tincture & Sublingual
4
4
4
4
4
+5.7%
CBG/THC 4:1 Focus Tincture (600mg CBG, 150mg THC, 30ml, 1oz)
Tincture & Sublingual
5
5
5
5
5
+3.9%
CBD/THC 1:1 Unscented Lotion (1000mg CBD, 1000mg THC, 50ml)
Topical
>10
>10
>10
7
6
-3.4%
CBD Lavender Scented with Arnica Lotion (1000mg CBD)
Topical
>10
>10
8
8
7
-5.9%
CBD/THC 1:1 Lavender Scented Lotion (1000mg CBD, 1000mg THC, 50ml)
Topical
>10
>10
>10
6
8
-29.8%
CBD Unscented Lotion (1000mg CBD)
Topical
9
>10
7
9
9
-58.2%
CBD Lavender Scented with Arnica Lotion (300mg CBD)
Topical
>10
>10
>10
>10
10
—
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market